Molecular study of the sodium-iodide symporter (NIS): A new field in thyroidology

Trends in Endocrinology and Metabolism

Volumn 11, Issue 3, 2000, Pages 99-105

  Dohan, Orsolya ^a   De La Vieja, Antonio ^a   Carrasco, Nancy ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN;

CANCER; CELL DIFFERENTIATION; ELECTROPHYSIOLOGY; HORMONE ACTION; HUMAN; MEMBRANE TRANSPORT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; REVIEW; THYROID CANCER;

EID: 0034120848     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00237-X     Document Type: Review

References (46)

1. Marine D., Feiss H.O. The absorption of potassium iodide by perfused thyroid glands and some of the factors modifying it. J. Pharmacol. Exp. Ther. 7:1915;557-576.
2. Taurog A. Hormone synthesis. Braverman L.E., Utiger R.D. The Thyroid (7th edn). 1996;17-84 Lippincott-Raven.
3. Nagataki S., Yokoyama N. Other factors regulating thyroid function. Autoregulation: effects of iodide. Braverman L.E., Utiger R.D. The Thyroid (7th edn). 1996;241-247 Lippincott-Raven.
4. Dai G.et al. Cloning and characterization of the thyroid iodide transporter. Nature. 379:1996;458-460.
5. World Health Organization (1996) Iodine Deficiency Disorders. Facts sheet No. 121. World Health Organization.
6. Dobson J.E. The iodine factor in health and evolution. Geograph. Rev. 88:1998;1-28.
7. - symporter (NIS): implications for its secondary structure model. J. Biol. Chem. 273:1998;22657-22663.
8. De la Vieja A.et al. Molecular analysis of the sodium/iodide symporter (NIS): impact on thyroid and extrathyroid pathophysiology. Physiol. Rev. 2000;. (in press).
9. Dai G.et al. The mediator of thyroidal iodide accumulation: the sodium/iodide symporter. Konings W.N.et al. Handbook of Biological Physics, Vol. II, Transport Processes in Eukaryotic and Prokaryotic Organisms. 1996;343-367 Elsevier.
10. Smanik P.A.et al. Cloning of the human sodium iodide symporter. Biochem. Biophys. Res. Commun. 226:1996;339-345.
11. Smanik P.A.et al. Expression, exon-intron organization and chromosome mapping of the human sodium iodide symporter. Endocrinology. 138:1997;3555-3558.
12. - symporter with an anti-COOH terminus antibody. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5568-5573.
13. Paire A.et al. Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. Relationship between its expression and activity. J. Biol. Chem. 272:1997;18245-18249.
14. Castro M.R.et al. Development of monoclonal antibodies against the human sodium iodide symporter: immunhistochemical characterization of this protein in thyroid cells. J. Clin. Endocrinol. Metab. 84:1999;2957-2962.
15. Artier F.et al. Iodide symporter gene expression in human thyroid tumors. J. Clin. Endocrinol. Metab. 83:1998;2493-2496.
16. - symporter distribution in human thyroid tissues: an immunohistochemical study. J. Clin. Endocrinol. Metab. 83:1998;4102-4106.
17. Saito T.et al. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J. Clin. Invest. 101:1998;1296-1300.
18. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology. 139:1998;4416-4419.
19. 131). J. Clin. Endocrinol. 9:1949;1153-1170.
20. - symporter: mechanism, stoichiometry, and specificity. J. Biol. Chem. 272:1997;27230-27238.
21. - symporter. Biochem. Biophys. Res. Comm. 231:1997;731-734.
22. 4, studied in FRTL-5 cells. Biochim. Biophys. Acta. 11:1998;231-237.
23. Kogai T.et al. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology. 138:1997;2227-2232.
24. - symporter mRNAs in dog thyroid. Mol. Cell. Endocrinol. 131:1997;195-203.
25. Wolff J., Chaikoff I.L. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J. Biol. Chem. 174:1948;555-560.
26. Wolff J.et al. The temporary nature of the inhibitory action of excess iodide on organic synthesis in the normal thyroid. Endocrinology. 45:1949;504-513.
27. Braverman L.E., Ingbar S.H. Changes in thyroidal function during adaptation to large doses of iodide. J. Clin. Invest. 42:1963;1216-1231.
28. Eng P.H.K.et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter (NIS) expression. Endocrinology. 140:1999;3404-3410.
29. Suzuki K.et al. Follicular thyreoglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide gene. Endocrinology. 140:1999;5422-5430.
30. Behr M.et al. Cloning of a functional promoter of the human sodium/iodide symporter gene. Biochem. J. 331:1998;359-363.
31. - symporter. J. Clin. Endocrinol. Metab. 83:1998;3247-3251.
32. Venkataraman M.G.et al. Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50. Thyroid. 8:1998;63-69.
33. - symporter gene. Mol. Endocrinol. 11:1997;1747-1755.
34. - symporter gene expression. Mol. Endocrinol. 12:1998;727-736.
35. Ohno M.et al. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol. Cell. Biol. 19:1999;2051-2060.
36. - symporter in the sera of patients with autoimmune thyroid disease. Biochem. Biophys. Res. Commun. 224:1996;92-95.
37. Endo T.et al. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity. Biochem. Biophys. Res. Commun. 228:1996;199-202.
38. - cotransporter as a potential autoantigen in thyroid autoimmune disease. Eur. J. Endocrinol. 132:1995;399-405.
39. Ajjan R.A.et al. The modulation of the human sodium iodide symporter activity by Graves sera. J. Clin. Endocrinol. Metab. 83:1998;1217-1221.
40. - symporter gene. Endocrinology. 138:1987;4493-4496.
41. Mandell R.B.et al. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res. 59:1999;661-668.
42. Spitzweg C.et al. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res. 59:1999;2136-2141.
43. Wolff J. Congenital goiter with defective iodide transport. Endocr. Rev. 4:1983;240-254.
44. - symporter. Nat. Genet. 16:1997;124-125.
45. Matsuda, A. and S. Kosugi, A. (1997) Homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J. Clin. Endocrinol. Metab. 82, 3966-3971.
46. - symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett. 429:1998;36-40.